Shenyang Northern Hospital

This study tests whether the drug colchicine can slow the buildup of plaque in heart arteries for people who have a specific genetic change called TET2-CHIP. About 120 adults who recently had a heart attack will receive colchicine or a placebo alongside their usual care. The goal…

This study compares two heart procedures for people with persistent atrial fibrillation (a type of irregular heartbeat lasting 6 months to 3 years). One group gets standard pulmonary vein isolation (PVI), and the other gets PVI plus an extra step targeting the Bachmann bundle. Th…

This study tests whether dapagliflozin, a drug typically used for diabetes, can reduce inflammation in the heart arteries of people who have had a heart attack but do not have diabetes or heart failure. About 110 participants will receive either the drug plus standard care or sta…

This study looks at whether a shorter course of blood thinners after heart stenting can reduce bleeding without increasing heart attacks or strokes. It involves 468 adults with acute coronary syndrome who have both high risks of clotting and bleeding. Participants will either get…

This study compares two blood thinners, bivalirudin and heparin, in over 5,000 heart patients who are at high risk of bleeding and need a procedure to open blocked arteries (PCI). The goal is to see if bivalirudin reduces serious complications like death, heart attack, stroke, or…

This study involves 3,500 adults with acute coronary syndrome who have received a heart stent and are at high risk for bleeding. Researchers will test a new quality control system to see if it helps doctors better manage antiplatelet medications, balancing clot prevention with bl…